Table of Contents Table of Contents
Previous Page  422 / 812 Next Page
Information
Show Menu
Previous Page 422 / 812 Next Page
Page Background

S418

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805

EV214

First episode of bipolar depression

after systemic lupus erythematosus in

a 51-year-old woman

V. Tardelli

, L. von Nielander , L. Sarin , J.A. Del Porto

Unifesp, Psychiatry, São Paulo, Brazil

Corresponding author.

Introduction

Systemic lupus erythematosus (SLE) is a multi-

system disease with a broad spectrum of clinical features and

neuropsychiatric manifestations that occur in up to 60% of patients.

Disease activity and treatment with corticosteroids may contribute

to this higher risk. It is also known that 36% of patients with SLE and

comorbid Bipolar Disorder (BD) have had their psychiatric onset

after they had been diagnosed with SLE.

Method

Single case report.

Results

A 51-year-old woman received a diagnosis of SLE

24months before the beginning of depressive symptoms. After her

diagnosis of SLE, seven years ago, she had three suicide attempts,

being diagnosedwithmajor depressive disorder. Fromthemon, she

had crises characterized by well-defined periods of 7 to 10 days

with sadness, reduced need for sleep, social isolation, irritability,

anger outbursts, impulsivity, racing thoughts and suicidal ideation.

After treatment with mood stabilizers (quetiapine 300mg/day and

lithium 600mg/day), she had a substantial reduction of symptoms

intensity and frequency.

Conclusion

The link between immune dysregulation, autoimmu-

nity and bipolar disorder may be closer than previously thought.

Even if the autoimmune disease is not directly etiologically related

to the psychiatric presentation, its detection is important due to

the high morbidity and mortality, considering the current under-

standing that Bipolar Disease is strongly related with inflammation

in central nervous system.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1199

EV215

A major depression or a bipolar

disorder type 2? A cased-focussed

psycopathological and

psychophysiological challenge for a

resident

I. Targa

1 ,

, J. Soler

2

, T. Gómez Alemany

3

1

Hospital Germanes Hospitalàries, Hospital de dia de Granollers,

Granollers, Spain

2

Hospital de dia, Hospital de dia, Granollers, Spain

3

Hospital de dia, Hospital de Granollers, Granollers, Spain

Corresponding author.

A 41-year-old woman is diagnosed with a major depression after

a few weeks of having been operated of a stomach reduction

(bariatric surgery). She goes into old antidepressant medication for

a few weeks with an increasing worsening of her state, at the point

she is sent to the emergency room with high irritability, intense

agitation, suicide thoughts as the highlight symptoms of what we

think to be a mixed episode of a bipolar disorder and how we ori-

ent the case during hospitalization. The patient follows both public

and private psychiatric services and after discharge fromacute hos-

pitalization, still with residual depressions symptoms, her private

psychiatrist substitutes the given treatment, including mood sta-

bilizers, by only antidepressants. Two weeks after discharge from

the hospital, the patient is relocated to our partial hospitalization

resource. During her stay in our resource, we decide to keep the

new treatment and diagnosis and increase the dosage of one of the

antidepressants, which immediately yields to hypomania symp-

toms, at what we conclude that our patient is better treated as

a bipolar type II with a mood stabilizer and low doses of an SRI.

We find this to be an interesting case in the both psychopatho-

logical and psychophysiological point of view. To understand the

case beyond clinical diagnosis, we discuss profoundly whether the

bariatric surgery may have a role as a trigger.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1200

EV216

Descriptive study of patients with

bipolar disorder and dyslipidemia

E. Tercelan Alvarez

1 ,

, M.P. Sierra San Miguel

2

,

L. Livianos Aldana

2

, C. Gomis Martinez

1

, V. Rodriguez Garcia

1

,

C. Gómez González

1

, L. Gonzalez Hernandez

1

,

M. Anibarro Tienda

1

, C. Ortigosa Silva

1

1

Hospital Universitario San Juan de Alicante, Psychiatry, San Juan de

Alicante, Spain

2

Hospital Universitario y Politècnico La Fe de Valencia, Psychiatry,

Valencia, Spain

Corresponding author.

Introduction

It is known the relationship between mental dis-

orders such as bipolar disorder and metabolic disorders such as

dyslipidemia, and therefore, increasing comorbid pathologies such

as heart disease.

Objectives

Determine in patients diagnosedwith bipolar disorder

and dyslipidemia, which are the epidemiological characteristics,

the diagnostic subtype and drug treatment prevalent.

Aims

Determine the profile of patients with bipolar disorder and

dyslipidemia.

Methods

Creation of a database and conduction of a descriptive

study with statistical analysis of the data extracted from the med-

ical records of 100 patients from a public hospital.

Results

Higher prevalence of diagnosis of bipolar disorder type I

on II (74% and 26%), male (54%) over female (46%), the age range

of 40–50 years, treated with antipsychotics more mood stabilizers

(62%) compared to mood stabilizer monotherapy (38%)

( Fig. 1 ).

Conclusions

Interventions should be conducted screening char-

acter and in patients with a diagnosis of bipolar disorder type I,

male, age between 30–50 years, treated with mood stabilizers plus

antipsychotics (with a preference for lithiumassociationwith olan-

zapine).

Fig. 1

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1201